REGISTERED NUMBER: 15324407 (England and Wales)

Unaudited Financial Statements

for the Period 1 January 2025 to 25 September 2025

for

Wick Pharma Ltd

T/A

Chase Meadow Pharmacy

Page

Company Information

1

Balance Sheet

2

DIRECTORS:

Mr J C Patel

Mr N Sivasubramaniam

REGISTERED OFFICE:

6 Chase Meadow Square

Narrow Hall Meadow

Warwick

CV34 6BT

REGISTERED NUMBER:

15324407 (England and Wales)

ACCOUNTANTS:

Xitax Limited

Pera Business Park

Nottingham Road

Melton Mowbray

Leicestershire

LE13 0PB

CURRENT ASSETS

1

NET CURRENT ASSETS

1

TOTAL ASSETS LESS CURRENT LIABILITIES

1

CAPITAL AND RESERVES

1

NOTE TO THE FINANCIAL STATEMENTS

1.	AVERAGE NUMBER OF EMPLOYEES

The average number of employees during the period was NIL.

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 25 September 2025.

The members have not required the company to obtain an audit of its financial statements for the period ended 25 September 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the Board of Directors and authorised for issue on 5 August 2026 and were signed on its behalf by:

Mr J C Patel - Director